A detailed history of J. Stern & Co. LLP transactions in Dexcom Inc stock. As of the latest transaction made, J. Stern & Co. LLP holds 23,438 shares of DXCM stock, worth $1.82 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
23,438
Previous 10,881 115.4%
Holding current value
$1.82 Million
Previous $1.23 Billion 27.36%
% of portfolio
0.17%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $803,648 - $1.46 Million
12,557 Added 115.4%
23,438 $1.57 Billion
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $925,942 - $1.18 Million
8,394 Added 337.52%
10,881 $1.23 Billion
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $130,781 - $160,414
1,145 Added 85.32%
2,487 $345 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $101,307 - $166,622
1,342 New
1,342 $163 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track J. Stern & Co. LLP Portfolio

Follow J. Stern & Co. LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Stern & Co. LLP, based on Form 13F filings with the SEC.

News

Stay updated on J. Stern & Co. LLP with notifications on news.